COVID-19 Pandemic Has Led to Telehealth Breakthroughs Including At Home Diagnostic Testing for Non-Muscle Invasive Bladder Cancer (NMIBC)
March 28, 2024
Alternative Strategies to Deliver Bladder Cancer Investigation During COVID-19 and Beyond
Neal Shore, MD, FACS
In this discussion Neal Shore, Sima Porten, and Tom Nifong discuss Cxbladder a non-invasive, urine-based laboratory test that measures the gene expression levels of five biomarkers in urine that effectively rule out or detect the presence of bladder cancer.
Impact on Bladder Cancer of Treatment Delays During the COVID-19 Pandemic
Zachary Klaassen, MD, MSc
Zachary Klaassen and Christopher Wallis join Alicia Morgans to discuss the management guide released by European Urology on how to best optimize the care of patients with GU malignancies during the COVID-19 pandemic.
Impact on Bladder Cancer of Treatment Delays During the COVID-19 Pandemic
Matthew Galsky, MD
Matthew Galsky joins Alicia Morgans to provide an update on how COVID-19 has affected his clinical practice and the treatment of bladder cancer patients at Mount Sinai hospital and the Tisch Cancer Institute.